Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Pharmacon
Tista Ayu Fortuna
(SINTA ID: 6781859) Faculty of Pharmacy, Universitas Muhammadiyah Surakarta
Health Professions Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Faktor – Faktor yang Mempengaruhi Komplikasi pada Pasien Diabetes Mellitus di RSUD Dr. Moewardi Tista Ayu Fortuna; Hidayah Karuniawati; Desti Purnamasari; Devi Etivia Purlinda
Pharmacon: Jurnal Farmasi Indonesia Vol 20, No 1 (2023)
Publisher : Universitas Muhammadiyah Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.23917/pharmacon.v20i1.21877

Abstract

Diabetes Mellitus (DM) is a disease characterized by hyperglycemia and disturbances in the metabolism of carbohydrates, fats, and proteins associated with absolute or relative deficiencies of insulin action and or secretion. The main problem for DM sufferers is that more than 50% of diabetic patients do not know about the disease and its complications, so patients will return to the hospital with high blood glucose levels accompanied by various complications. The study aims to determine the factors that can cause complications in patients with diabetes mellitus. This research is a non-experimental study with a cross-sectional approach. The data were analyzed using SPSS with a Chi-square or Kruskal-Wallis and multivariate logistic regression test. Body mass index and duration of diabetes are significantly associated with the incidence of complications (p-value 0.05). Patients with an abnormal body mass index are 4.184x more at risk of complications than patients with a normal body mass index (RR 4.184 CI 1.581 – 11.070). In addition, patients with diabetes duration ≥5 years were 4.121 times more at risk of complications than patients with diabetes durations 5 years (RR 4.121 CI 1.570 – 10.816). The most common complication suffered by diabetic patients in this study was hypertension in 46 patients (41%), and the most common therapeutic regimen received by patients was oral hypoglycemia in 50 patients (52%). 
Co-Authors Desti Purnamasari Devi Etivia Purlinda Hidayah Karuniawati